Boston Scientific Corporation filed an 8-K on September 23, 2026, disclosing that Executive Vice President and Group President Arthur C. Butcher has informed the company of his decision to retire, with an effective retirement date of January 1, 2027.
Key Highlights
- Retirement announced: Arthur C. Butcher notified Boston Scientific on September 21, 2026 of his decision to retire from his role as Executive Vice President and Group President, MedSurg and Asia Pacific.
- Effective date: The retirement from his executive role is effective January 1, 2027.
- Senior advisor role: Butcher is expected to remain with the company as a senior advisor through February 26, 2027, which the filing defines as the "Retirement Date."
- Compensation during advisory period: As senior advisor, Butcher will receive a base salary at his current annual base salary of $780,000, prorated through the Retirement Date.
- Retirement Agreement planned: The company expects to enter into a Retirement Agreement with Butcher effective as of the Retirement Date, with payments and benefits described as "materially consistent" with those under the company's Executive Retirement Plan, 2026 Annual Bonus Plan, and Long-Term Incentive Program.
Boston Scientific Discloses Butcher Retirement and Transition Terms
According to the filing, Arthur C. Butcher informed Boston Scientific Corporation on September 21, 2026 that he has decided to retire from his position as Executive Vice President and Group President, MedSurg and Asia Pacific. His departure from that executive role is set to take effect January 1, 2027, as disclosed under Item 5.02 of the 8-K.
The filing states that Butcher is expected to remain with the company in a senior advisor capacity from January 1, 2027 through February 26, 2027, or any earlier date designated as the Retirement Date. During this advisory period, the company disclosed he will receive a base salary consistent with his current annual base salary of $780,000, prorated through the Retirement Date.
The company further disclosed that it expects to enter into a Retirement Agreement with Butcher effective as of the Retirement Date. According to the filing, that agreement will provide payments and benefits "materially consistent" with those Butcher is entitled to under the company's Executive Retirement Plan, 2026 Annual Bonus Plan, and Long-Term Incentive Program and equity awards granted thereunder, each of which has been previously filed with the SEC. The 8-K was signed by Susan Thompson, Vice President, Chief Corporate Counsel and Assistant Secretary, and was filed on NYSE:BSX on September 23, 2026.
What Was Disclosed
Boston Scientific's September 23, 2026 8-K disclosed the planned retirement of EVP Arthur C. Butcher effective January 1, 2027, his transition to a senior advisor role through February 26, 2027, his prorated $780,000 annual base salary during that period, and the company's intent to execute a formal Retirement Agreement.



Please wait processing your request...